Evidence map›Paper›PMID 29298988›Full record

ArticleCell death & disease2018

Oxidative stress preconditioning of mouse perivascular myogenic progenitors selects a subpopulation of cells with a distinct survival advantage in vitro and in vivo.

Cesare Gargioli, Giuseppina Turturici, Maria M Barreca, Walter Spinello, Claudia Fuoco, Stefano Testa, Salvatore Feo, Stefano M Cannata, Giulio Cossu, Gabriella Sconzo and 1 more

Abstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Stem/progenitor cell-based therapy for Duchenne muscular dystrophy.Frontiers in cell and developmental biology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Stem cell therapy for muscular dystrophies.The Journal of clinical investigation · 2020
    Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Cesare GargioliDepartment of Biology, University of Rome "Tor Vergata", Rome, 00133, Italy.
Giuseppina TurturiciDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Palermo, 90128, Italy.
Maria M BarrecaDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Palermo, 90128, Italy.
Walter SpinelloDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Palermo, 90128, Italy.
Claudia FuocoDepartment of Biology, University of Rome "Tor Vergata", Rome, 00133, Italy.
Stefano TestaDepartment of Biology, University of Rome "Tor Vergata", Rome, 00133, Italy.
Salvatore FeoDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Palermo, 90128, Italy.
Stefano M CannataDepartment of Biology, University of Rome "Tor Vergata", Rome, 00133, Italy.
Giulio CossuDivision of Cell Matrix Biology and Regenerative Medicine, University of Manchester, Oxford Road, M13 9PL, Manchester, UK.
Gabriella SconzoDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Palermo, 90128, Italy.
Fabiana GeraciDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Palermo, 90128, Italy. fabiana.geraci@unipa.it.ORCID 0000-0001-9734-1765

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell engraftment, survival and integration during transplantation procedures represent the crux of cell-based therapies. Thus, there have been many studies focused on improving cell viability upon implantation. We used severe oxidative stress to select for a mouse mesoangioblast subpopulation in vitro and found that this subpopulation retained self-renewal and myogenic differentiation capacities while notably enhancing cell survival, proliferation and migration relative to unselected cells. Additionally, this subpopulation of cells presented different resistance and recovery properties upon oxidative stress treatment, demonstrating select advantages over parental mesoangioblasts in our experimental analysis. Specifically, the cells were resistant to oxidative environments, demonstrating survival, continuous self-renewal and improved migration capability. The primary outcome of the selected cells was determined in in vivo experiments in which immunocompromised dystrophic mice were injected intramuscularly in the tibialis anterior with selected or non-selected mesoangioblasts. Resistant mesoangioblasts exhibited markedly enhanced survival and integration into the host skeletal muscle, accounting for a more than 70% increase in engraftment compared with that of the unselected mesoangioblast cell population and leading to remarkable muscle recovery. Thus, the positive effects of sorting on mesoangioblast cell behaviour in vitro and in vivo suggest that a selection step involving oxidative stress preconditioning may provide a novel methodology to select for resistant cells for use in regenerative tissue applications to prevent high mortality rates upon transplantation.

Indexed as

AnimalsCell Cycle CheckpointsCell DifferentiationCell LineCell MovementCell SurvivalHydrogen PeroxideMatrix Metalloproteinase 2MiceMice, SCIDMuscle, SkeletalMuscular Dystrophy, AnimalOxidative Stressp38 Mitogen-Activated Protein KinasesProtein IsoformsReactive Oxygen SpeciesHydrogen PeroxideMatrix Metalloproteinase 2p38 Mitogen-Activated Protein KinasesProtein IsoformsReactive Oxygen SpeciesSarcoglycans

Identifiers

PMID29298988
PMCPMC5849040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.